Blacklock's Reporter

Executives at a federal agency declined to testify at the Commons health committee after threatening to “push back” against patient groups like Cystic Fibrosis Canada. Threats by the Patented Medicine Prices Review Board were detailed in Access To Information records: “We can all make assumptions on why they refused to show up.”